Most studies of experimental amyloid A protein (AA) amyloidosis in mic
e have been performed in type A mice with BALB/c as the prototype. In
these mice the products of two genes, SAA1 and SAA2, are the major apo
-SAA isoforms on high density lipoprotein (HDL). Of these two isoforms
, that differ at nine amino acids, only apo-SAA2 is rapidly cleared an
d deposited as amyloid fibrils. No mouse strain has ever been shown to
be completely resistant to amyloid induction. We have found the CE/J
mouse strain to be exceedingly resistant to amyloidogenesis. Data indi
cate that this resistance is not due to a lack of apo-SAA synthesis bu
t rather resides in the unique apo-SAA isoform in this strain. CE/J mi
ce have a single major apo-SAA isoform (pI 6.15) the product of a sing
le gene. This is a hybrid molecule with features of both apo-SAA1 and
apo-SAA2, differing from the latter at only six amino acids. When CD s
tudies were performed to explore the structural relationship of this i
soform to apo-SAA1 and apo-SAA2, we found that when bound to heparan s
ulfate proteoglycan the CE/J pI 6.15 isoform fails to undergo the beta
-sheet folding typical for apo-SAA2. This evidence suggests that the f
olding effect of heparan sulfate proteoglycan on apo-SAA2 is important
in amyloid formation.